Analysts: Clovis Oncology Inc (CLVS.OQ)
CLVS.OQ on NASDAQ Stock Exchange Global Select Market
77.36USD
1 Aug 2013
77.36USD
1 Aug 2013
Price Change (% chg)
$-0.52 (-0.67%)
$-0.52 (-0.67%)
Prev Close
$77.88
$77.88
Open
$79.25
$79.25
Day's High
$81.75
$81.75
Day's Low
$74.03
$74.03
Volume
135,728
135,728
Avg. Vol
103,511
103,511
52-wk High
$86.29
$86.29
52-wk Low
$11.19
$11.19
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -0.64 | December | 2 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 1 | 1 | 1 | 1 |
| (2) OUTPERFORM | 4 | 3 | 2 | 2 |
| (3) HOLD | 0 | 0 | 1 | 1 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.80 | 1.75 | 2.00 | 2.00 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 4 | 0.00 | 0.00 | 0.00 | -- |
| Quarter Ending Dec-13 | 4 | 0.00 | 0.00 | 0.00 | -- |
| Year Ending Dec-13 | 4 | 0.00 | 0.00 | 0.00 | 0.00 |
| Year Ending Dec-14 | 4 | 0.00 | 0.00 | 0.00 | 127.70 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 4 | -0.64 | -0.54 | -0.77 | -- |
| Quarter Ending Dec-13 | 4 | -0.71 | -0.56 | -0.90 | -- |
| Year Ending Dec-13 | 5 | -2.67 | -2.23 | -3.11 | -2.39 |
| Year Ending Dec-14 | 5 | -3.37 | -2.88 | -3.81 | -1.04 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Dec-12 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Sep-12 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Jun-12 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Mar-12 | 0.00 | 0.00 | 0.00 | 0.00 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Quarter Ending Dec-13 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Year Ending Dec-13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Year Ending Dec-14 | 0.00 | 0.00 | 0.00 | 33.88 | 127.70 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
| Earnings | ||||
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates